Abstract Purpose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
vaccines have been reported to trigger immune side effects. Type 1 diabetes as a …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been used
worldwide to control the coronavirus disease pandemic. However, several adverse effects …

During the ongoing coronavirus disease 2019 (COVID-19) pandemic, it is critical to ensure
the safety of COVID-19 vaccines. We herein report a 51-year-old Japanese woman who …

The epidemic of coronavirus disease‐2019 (COVID‐19) is the major public health issue in
the world. COVID‐19 vaccines are one of the most effective strategies against COVID‐19 …

The mRNA-based BNT162b2 vaccine has demonstrated high efficacy against severe SARS-
CoV-2. However, data regarding immune response in people with diabetes mellitus (DM) …

Patients with type 1 diabetes (T1D) may develop severe outcomes during coronavirus
disease 2019 (COVID-19), but their ability to generate an immune response against the …

Abstract Introduction In Hong Kong, CoronaVac and BNT162b2 have been approved for
emergency use owing to the coronavirus disease 2019 (COVID-19) pandemic. Reactions …

The vaccine for the coronavirus disease 2019 (COVID‐19) has been reported to potentially
cause or worsen diabetes. A 73‐year‐old Japanese woman received two doses of Moderna …

The ravages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide
have sped up the development of relevant vaccines, which is accompanied by public …

During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccination-induced
hyperglycemia and related complications have been reported. However, there have been …